Steve Harr insider trades

Open-market stock purchases and sales by Steve Harr, President & CEO at Sana Biotechnology, Inc, from SEC Form 4 filings since Mar 3, 2015.

Recent trades

DateStockTradeValue
Mar 9, 2026SANA Sana Biotechnology, IncSold (not open market)$36.1K
Mar 9, 2026SANA Sana Biotechnology, IncSold (not open market)$39.7K
Mar 7, 2026SANA Sana Biotechnology, IncBought (not open market)—
Mar 6, 2026SANA Sana Biotechnology, IncBought (not open market)—
Mar 5, 2026SANA Sana Biotechnology, IncBought (not open market)—
Mar 5, 2026SANA Sana Biotechnology, IncBought (not open market)—

Companies traded

  • SANA Sana Biotechnology, Inc: other filings, last Mar 9, 2026
  • LOXO Loxo Oncology, Inc: other filings, last Jun 13, 2018
  • JUNO Juno Therapeutics, Inc: 15 sales, last Mar 5, 2018

Get free alerts when Steve Harr files a new trade →